These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15562106

  • 1. Prick testing for neuromuscular blocking drugs.
    Dhonneur G.
    Anesth Analg; 2004 Dec; 99(6):1880-1881. PubMed ID: 15562106
    [No Abstract] [Full Text] [Related]

  • 2. Skin sensitivity to rocuronium and vecuronium: prick-tests are not intradermal test.
    Dhonneur G.
    Anesth Analg; 2005 May; 100(5):1539-1540. PubMed ID: 15845728
    [No Abstract] [Full Text] [Related]

  • 3. Skin sensitivity to rocuronium and vecuronium: a randomized controlled prick-testing study in healthy volunteers.
    Dhonneur G, Combes X, Chassard D, Merle JC.
    Anesth Analg; 2004 Apr; 98(4):986-989. PubMed ID: 15041585
    [Abstract] [Full Text] [Related]

  • 4. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM, Moneret-Vautrin DA, Leynadier F, Laxenaire MC.
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [Abstract] [Full Text] [Related]

  • 5. Rocuronium anaphylaxis and multiple neuromuscular blocking drug sensitivities.
    Matthey P, Wang P, Finegan BA, Donnelly M.
    Can J Anaesth; 2000 Sep; 47(9):890-3. PubMed ID: 10989860
    [Abstract] [Full Text] [Related]

  • 6. Rocuronium: high risk for anaphylaxis?
    Rose M, Fisher M.
    Br J Anaesth; 2001 May; 86(5):678-82. PubMed ID: 11575345
    [Abstract] [Full Text] [Related]

  • 7. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events.
    Bhananker SM, O'Donnell JT, Salemi JR, Bishop MJ.
    Anesth Analg; 2005 Sep; 101(3):819-822. PubMed ID: 16115997
    [Abstract] [Full Text] [Related]

  • 8. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide.
    Ebo DG, Bridts CH, Hagendorens MM, Mertens CH, De Clerck LS, Stevens WJ.
    Allergy; 2006 Aug; 61(8):935-9. PubMed ID: 16867045
    [Abstract] [Full Text] [Related]

  • 9. Sugammadex and rocuronium-induced anaphylaxis.
    Takazawa T, Mitsuhata H, Mertes PM.
    J Anesth; 2016 Apr; 30(2):290-7. PubMed ID: 26646837
    [Abstract] [Full Text] [Related]

  • 10. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
    Pedersen AF, Green S, Rose MA.
    Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
    [Abstract] [Full Text] [Related]

  • 11. [Severe anaphylactic reactions after administration of rocuronium].
    Barthelet Y, Ryckwaert Y, Plasse C, Bonnet-Boyer MC, d'Athis F.
    Ann Fr Anesth Reanim; 1999 Oct; 18(8):896-900. PubMed ID: 10575503
    [Abstract] [Full Text] [Related]

  • 12. Vecuronium, like rocuronium, causes pain on injection.
    Ti LK, Dhara SS.
    Br J Anaesth; 1998 Sep; 81(3):487. PubMed ID: 9861154
    [No Abstract] [Full Text] [Related]

  • 13. Intraoperative anaphylaxis to neuromuscular blocking agents: the incidence over 9 years at two tertiary hospitals in South Korea: A retrospective observational study.
    Cho YJ, Ju JW, Sim H, Lee JH, Hong DM, Kim TK, Min JJ, Song WJ, Kang HR, Cho SH, Jeon Y.
    Eur J Anaesthesiol; 2016 May; 33(5):368-78. PubMed ID: 26575006
    [Abstract] [Full Text] [Related]

  • 14. Sugammadex approved to reverse NMBA effects.
    Thompson CA.
    Am J Health Syst Pharm; 2016 Feb 01; 73(3):100. PubMed ID: 26796899
    [No Abstract] [Full Text] [Related]

  • 15. [Allergy investigations after two cases of adverse reactions to a neuromuscular blocking agent and management for subsequent general anaesthesia].
    Louvier N, Chomel A, Collet E, Juniot A, Pillet M.
    Ann Fr Anesth Reanim; 2003 Jan 01; 22(1):54-7. PubMed ID: 12738022
    [Abstract] [Full Text] [Related]

  • 16. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011.
    Sadleir PH, Clarke RC, Bunning DL, Platt PR.
    Br J Anaesth; 2013 Jun 01; 110(6):981-7. PubMed ID: 23335568
    [Abstract] [Full Text] [Related]

  • 17. Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique.
    Berg CM, Heier T, Wilhelmsen V, Florvaag E.
    Acta Anaesthesiol Scand; 2003 May 01; 47(5):576-82. PubMed ID: 12699516
    [Abstract] [Full Text] [Related]

  • 18. Allergy to rocuronium: from clinical suspicion to correct diagnosis.
    Leysen J, Bridts CH, De Clerck LS, Vercauteren M, Lambert J, Weyler JJ, Stevens WJ, Ebo DG.
    Allergy; 2011 Aug 01; 66(8):1014-9. PubMed ID: 21375539
    [Abstract] [Full Text] [Related]

  • 19. Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks.
    Hunter JM, Blobner M.
    Br J Anaesth; 2024 Mar 01; 132(3):461-465. PubMed ID: 38135525
    [Abstract] [Full Text] [Related]

  • 20. Early skin and challenge testing after rocuronium anaphylaxis.
    Schulberg EM, Webb AR, Kolawole H.
    Anaesth Intensive Care; 2016 May 01; 44(3):425-7. PubMed ID: 27246945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.